Lusutrombopag for treatment of thrombocytopenia in patients with chronic liver disease who are undergoing planned invasive procedures: pooled safety analysis of bleeding-related adverse events

被引：1
|
作者：
Giannini, Edoardo Giovanni [1 ]
Kano, Takeshi [2 ]
Ochiai, Toshimitsu [3 ]
Bentley, Roy [4 ]
Shrestha, Pomy [5 ]
机构：
[1] Univ Genoa, Dipartimineto Med Interna & Specialita Med, Genoa, Italy
[2] Shionogi & Co Ltd, Global Project Management Dept, Osaka, Japan
[3] Shionogi & Co Ltd, Biostat Ctr, Osaka, Japan
[4] Shionogi Inc, US Global Market Access, Florham Pk, NJ USA
[5] Shionogi Inc, Prod Safety & Pharmacovigilance, Florham Pk, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31280-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-038
引用
收藏
页码：E643 / E643
页数：1
相关论文
共 44 条
  • [11] Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures: A Systematic Review and Meta-analysis
    Beran, Azizullah
    Ghazaleh, Sami
    Mhanna, Mohammed
    Srour, Omar
    Chuang, Justin
    Shaear, Mohammad
    Al-Abboodi, Yasir
    Nawras, Ali
    Assaly, Ragheb
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (05) : E599 - E603
  • [12] Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
    Michelle E. Orme
    Roy Bentley
    Stephen Marcella
    Markus Peck-Radosavljevic
    Rodolphe Perard
    Heiner Wedemeyer
    Hitoshi Yoshiji
    Kosh Agarwal
    Geoffrey Dusheiko
    [J]. Advances in Therapy, 2022, 39 : 4169 - 4188
  • [13] LUSUTROMBOPAG FOR PATIENTS WITH CHRONIC LIVER DISEASE AND THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Jaber, Fouad
    Beran, Azizullah
    Mohamed, Mouhand F.
    Beas, Renato
    Montalvan-Sanchez, Eleazar E.
    Elfert, Khaled
    Alsakarneh, Saqr
    Muhanna, Adel
    Bierman, Thomas
    Ghoz, Hassan
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1330 - S1330
  • [14] Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
    Orme, Michelle E.
    Bentley, Roy
    Marcella, Stephen
    Peck-Radosavljevic, Markus
    Perard, Rodolphe
    Wedemeyer, Heiner
    Yoshiji, Hitoshi
    Agarwal, Kosh
    Dusheiko, Geoffrey
    [J]. ADVANCES IN THERAPY, 2022, 39 (09) : 4169 - 4188
  • [15] Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance
    Sasaki, Ritsue
    Shiino, Chikako
    Imawari, Michio
    Bentley, Roy
    Cai, Bin
    Yoshida, Manami
    Afdhal, Nezam
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (10) : 1169 - 1181
  • [16] Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
    Nishida, Yuno
    Kawaoka, Tomokazu
    Imamura, Michio
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ohya, Kazuki
    Daijo, Kana
    Teraoka, Yuji
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Yamauchi, Masami
    Hiramatsu, Akira
    Tsuge, Masataka
    Aikata, Hiroshi
    Takahashi, Shoichi
    Hayes, C. Nelson
    Fukuhara, Takayuki
    Tsuji, Keiji
    Arataki, Keiko
    Nagaoki, Yuko
    Aisaka, Yasuyuki
    Kamada, Koji
    Kodama, Hideaki
    Chayama, Kazuaki
    [J]. INTERNAL MEDICINE, 2021, 60 (06) : 829 - 837
  • [17] Safety and effectiveness of lusutrombopag in patients who have chronic liver disease with thrombocytopenia and undergoing invasive procedures: Real-world post-marketing surveillance in Japan
    Yoshiji, Hitoshi
    Suzuki, Junto
    Imasaki, Masafumi
    Tsukimura, Eri
    Miyano, Makiko
    Kurosaki, Masayuki
    [J]. HEPATOLOGY RESEARCH, 2023, 53 (11) : 1105 - 1116
  • [18] Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
    Katsube, Takayuki
    Shimizu, Ryosuke
    Fukuhara, Takahiro
    Kano, Takeshi
    Wajima, Toshihiro
    [J]. HEPATOLOGY, 2018, 68 : 478A - 478A
  • [19] Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
    Katsube, Takayuki
    Shimizu, Ryosuke
    Fukuhara, Takahiro
    Kano, Takeshi
    Wajima, Toshihiro
    [J]. CLINICAL PHARMACOKINETICS, 2019, 58 (11) : 1469 - 1482
  • [20] Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
    Takayuki Katsube
    Ryosuke Shimizu
    Takahiro Fukuhara
    Takeshi Kano
    Toshihiro Wajima
    [J]. Clinical Pharmacokinetics, 2019, 58 : 1469 - 1482
12345